These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25039759)

  • 21. Anticoagulants and cancer survival.
    Piccioli A; Falanga A; Prandoni P
    Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spontaneous deep venous thrombosis. First symptom of a neoplasm?].
    Bischoff A
    MMW Fortschr Med; 2007 May; 149(22):16. PubMed ID: 18074457
    [No Abstract]   [Full Text] [Related]  

  • 24. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Harrington DW; Jindeel A
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227972
    [No Abstract]   [Full Text] [Related]  

  • 25. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Zhan H; Zheng H
    JAMA; 2007 Jan; 297(3):261-2; author reply 263. PubMed ID: 17227970
    [No Abstract]   [Full Text] [Related]  

  • 26. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 27. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Edwards JL
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227973
    [No Abstract]   [Full Text] [Related]  

  • 28. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Bhala N; Shah A; King A; Molugu C
    JAMA; 2007 Jan; 297(3):261; author reply 263. PubMed ID: 17227971
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of venous thrombosis in a cancer patient].
    Lepäntalo A
    Duodecim; 2015; 131(7):637-44. PubMed ID: 26233981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer related venous thromboembolism - prophylaxis and therapy.
    Gary T
    Vasa; 2014 Jul; 43(4):245-51. PubMed ID: 25007902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of anticoagulant drugs in cancer.
    Falanga A; Piccioli A
    Curr Opin Pulm Med; 2005 Sep; 11(5):403-7. PubMed ID: 16093813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reply].
    Barrellier MT
    J Mal Vasc; 2013 Jul; 38(4):282. PubMed ID: 23755879
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
    Gould MK; Dembitzer AD; Sanders GD; Garber AM
    Ann Intern Med; 1999 May; 130(10):789-99. PubMed ID: 10366368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International normalized ratio and anticoagulation.
    Theerman MR
    Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
    [No Abstract]   [Full Text] [Related]  

  • 40. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.